Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a report issued on Monday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of NYSE:RVP opened at $1.17 on Monday. The firm has a 50 day moving average of $1.10 and a 200 day moving average of $1.15. The company has a quick ratio of 8.18, a current ratio of 11.02 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $35.03 million, a price-to-earnings ratio of -4.50 and a beta of 2.08. Retractable Technologies has a 52 week low of $0.87 and a 52 week high of $1.34.

Retractable Technologies (NYSE:RVPGet Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 EPS for the quarter. The firm had revenue of $7.60 million during the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%.

Insider Buying and Selling at Retractable Technologies

In other news, CEO Thomas J. Shaw acquired 48,635 shares of Retractable Technologies stock in a transaction that occurred on Thursday, May 16th. The stock was purchased at an average price of $1.03 per share, for a total transaction of $50,094.05. Following the purchase, the chief executive officer now directly owns 14,417,148 shares in the company, valued at approximately $14,849,662.44. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last ninety days, insiders bought 150,816 shares of company stock valued at $156,305. 55.00% of the stock is currently owned by insiders.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.